T. Rowe Price Associates’s AdaptHealth AHCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $770K | Buy |
81,550
+3,254
| +4% | +$30.7K | ﹤0.01% | 2097 |
|
|
2025
Q1 | $849K | Buy |
78,296
+4,306
| +6% | +$46.7K | ﹤0.01% | 2037 |
|
|
2024
Q4 | $705K | Buy |
73,990
+10,451
| +16% | +$99.6K | ﹤0.01% | 2123 |
|
|
2024
Q3 | $714K | Buy |
63,539
+1,150
| +2% | +$12.9K | ﹤0.01% | 2107 |
|
|
2024
Q2 | $624K | Buy |
62,389
+4,515
| +8% | +$45.2K | ﹤0.01% | 2103 |
|
|
2024
Q1 | $667K | Buy |
57,874
+4,575
| +9% | +$52.7K | ﹤0.01% | 2087 |
|
|
2023
Q4 | $389K | Buy |
53,299
+5,464
| +11% | +$39.9K | ﹤0.01% | 2279 |
|
|
2023
Q3 | $436K | Buy |
47,835
+8,972
| +23% | +$81.8K | ﹤0.01% | 2171 |
|
|
2023
Q2 | $473K | Buy |
38,863
+1,211
| +3% | +$14.7K | ﹤0.01% | 2155 |
|
|
2023
Q1 | $469K | Buy |
37,652
+984
| +3% | +$12.3K | ﹤0.01% | 2132 |
|
|
2022
Q4 | $705K | Sell |
36,668
-2,589
| -7% | -$49.8K | ﹤0.01% | 1970 |
|
|
2022
Q3 | $738K | Buy |
39,257
+4,742
| +14% | +$89.1K | ﹤0.01% | 1920 |
|
|
2022
Q2 | $623K | Buy |
34,515
+7,977
| +30% | +$144K | ﹤0.01% | 2121 |
|
|
2022
Q1 | $425K | Buy |
26,538
+13,089
| +97% | +$210K | ﹤0.01% | 2402 |
|
|
2021
Q4 | $329K | Sell |
13,449
-10,738
| -44% | -$263K | ﹤0.01% | 2559 |
|
|
2021
Q3 | $563K | Sell |
24,187
-5,979
| -20% | -$139K | ﹤0.01% | 2321 |
|
|
2021
Q2 | $827K | Buy |
30,166
+5,101
| +20% | +$140K | ﹤0.01% | 2147 |
|
|
2021
Q1 | $921K | Buy |
25,065
+13,960
| +126% | +$513K | ﹤0.01% | 2092 |
|
|
2020
Q4 | $417K | Buy |
+11,105
| New | +$417K | ﹤0.01% | 2313 |
|